✦ LIBER ✦

Prophylaxis of invasive mycoses in solid organ transplantation

✍ Scribed by Kyle P. Radack; Barbara D. Alexander

Book ID: 107542767
Publisher: Springer
Year: 2009
Tongue: English
Weight: 357 KB
Volume: 11
Category: Article
ISSN: 1523-3847
DOI: 10.1007/s11908-009-0062-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The case for cytomegalovirus prophylaxis

The case for cytomegalovirus prophylaxis in solid organ transplantation

✍ David R. Snydman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract Cytomegalovirus prevention strategies have been debated for the past decade. This review argues in favour of the prophylaxis strategy. Clinical trials comparing prophylaxis to pre‐emptive therapy have, thus far, had insufficient power to differentiate strategies, especially with regard

Anti-cytomegalovirus prophylaxis in soli

Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients

✍ M. E. Falagas; K. Z. Vardakas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

Invasive Aspergillosis in Solid Organ Tr

Invasive Aspergillosis in Solid Organ Transplant Recipients

✍ N. Singh; S. Husain; the AST Infectious Diseases Community of Practice 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Duration of prophylaxis with trimethopri

Duration of prophylaxis with trimethoprim–sulfamethoxazole in patients undergoing solid organ transplantation

✍ P. Malhotra, S. D. Rai, D. Hirschwerk 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Cytomegalovirus prophylaxis in solid org

Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues

✍ C Legendre; E Thervet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Prophylaxis for CMV should now replace p

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation

✍ Gregory D. Hart; Carlos V. Paya 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract Cytomegalovirus is a significant cause of morbidity and mortality in transplantation. Controversy exists concerning whether prophylactic or pre‐emptive therapy is the optimal strategy for preventing CMV disease. In addition, CMV impacts the transplanted graft, transplant recipient and t